Gong Lin, Tang Na, Chen Dongke, Sun Kaiwen, Lan Ruiting, Zhang Wen, Zhou Haijian, Yuan Min, Chen Xia, Zhao Xiaofei, Che Jie, Bai Xuemei, Zhang Yunfei, Xu Hongtao, Walsh Timothy R, Lu Jinxing, Xu Jianguo, Li Juan, Feng Jie
State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, National Institute for Communicable Disease Control and Prevention, China CDC, Beijing, China.
Wuhan Centers for Disease Prevention and Control, Wuhan, China.
Front Microbiol. 2020 Sep 11;11:2068. doi: 10.3389/fmicb.2020.02068. eCollection 2020.
sequence type 131 (ST131) is well known for its multidrug resistance profile. Carbapenems have been considered the treatment of choice for ST131 infections, and resistance to carbapenems is emerging due to the acquisition of carbapenemase-encoding genes. In this study, 45 carbapenem-resistant strains were collected in a hospital. The resistance mechanisms, plasmid profiles, and genetic relatedness of these strains were determined. Phylogenetic relationships between these strains were assessed by molecular profiling and aligned with patient clinical details. The genetic context of was analyzed to trace the potential dissemination of . The 45 carbapenem-resistant ST131 strains were closely related. Initially prevalent only in a single ward, ST131 subsequently spread to other ward, resulting in a respiratory infection outbreak of carbapenem-resistant ST131. Eight of the 30 patients died within 28 days of the first isolation of ST131. The -positive plasmid profiles suggest that the carbapenem resistance was due to the acquisition by ST131 of transmissible plasmids pE0272_KPC and pE0171_KPC carrying . Additionally, diverse multidrug resistance elements were transferred and rearranged between these plasmids mediated by IS26. Our research indicates that clinical attention should be paid to the importance of ST131 in respiratory infections and the spread of -carrying ST131.
序列类型131(ST131)以其多重耐药性而闻名。碳青霉烯类药物一直被认为是治疗ST131感染的首选药物,由于获得了编码碳青霉烯酶的基因,对碳青霉烯类药物的耐药性正在出现。在本研究中,一家医院收集了45株耐碳青霉烯类菌株。确定了这些菌株的耐药机制、质粒图谱和遗传相关性。通过分子图谱评估这些菌株之间的系统发育关系,并与患者临床细节进行比对。分析了blaKPC的基因背景以追踪blaKPC的潜在传播情况。这45株耐碳青霉烯类的ST131菌株密切相关。ST131最初仅在一个病房流行,随后传播到其他病房,导致耐碳青霉烯类ST131的呼吸道感染暴发。30例患者中有8例在首次分离出ST131后的28天内死亡。blaKPC阳性的质粒图谱表明,碳青霉烯类耐药性是由于ST131获得了携带blaKPC的可传播质粒pE0272_KPC和pE0171_KPC。此外,不同的多重耐药元件在这些质粒之间由IS26介导进行转移和重排。我们的研究表明,临床应关注ST131在呼吸道感染中的重要性以及携带blaKPC的ST131的传播情况。
Front Microbiol. 2020-11-13
J Antimicrob Chemother. 2014-3
Front Microbiol. 2023-3-23
Microorganisms. 2023-7-25
BMC Microbiol. 2023-4-20
Antibiotics (Basel). 2022-11-25
Antimicrob Agents Chemother. 2018-1-25
Nucleic Acids Res. 2017-1-4